Siying Lin

Siying Lin

Auto-generated profile, based on publicly available information

Siying Lin

Manchester Centre for Genomic Medicine and Department of Ophthalmology, Manchester University NHS Foundation Trust, Manchester, UK

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2024 in Ophthalmology Retina
Verified
Journal Article
Open access
SLSiying Lin
Siying Lin
SVSandra Vermeirsch
Sandra Vermeirsch
NPNikolas Pontikos
Nikolas Pontikos
MMMaria Pilar Martin-Gutierrez
Maria Pilar Martin-Gutierrez
MVMalena Daich Varela
Malena Daich Varela
GAGavin Arno
Gavin Arno
Inherited retinal disease (IRD) is a leading cause of blindness. Recent advances in gene-directed therapies highlight the importance of understanding the genetic basis of these disorders. This study details the molecular spectrum in a large United Kingdom (UK) IRD patient cohort. Retrospective study of electronic patient records. Patients with IRD who attended the Genetics Service at Moorfields Eye Hospital between 2003 and July 2020, in whom a molecular diagnosis was identified. Genetic testing was undertaken via a combination of single-gene testing, gene panel testing, whole exome sequencing, and more recently, whole genome sequencing. Likely disease-causing variants were identified from entries within the genetics module of the hospital electronic patient record (OpenEyes Electronic Medical Record). Analysis was restricted to only genes listed in the Genomics England PanelApp R32 Retinal Disorders panel (version 3.24), which includes 412 genes associated with IRD. Manual curation ensured consistent variant annotation and included only plausible disease-associated variants. Detailed analysis was performed for variants in the 5 most frequent genes (ABCA4, USH2A, RPGR, PRPH2, and BEST1), as well as for the most common variants encountered in the IRD study cohort. We identified 4415 individuals from 3953 families with molecularly diagnosed IRD (variants in 166 genes). Of the families, 42.7% had variants in 1 of the 5 most common IRD genes. Complex disease alleles contributed to disease in 16.9% of affected families with ABCA4-associated retinopathy. USH2A exon 13 variants were identified in 43% of affected individuals with USH2A-associated IRD. Of the RPGR variants, 71% were clustered in the ORF15 region. PRPH2 and BEST1 variants were associated with a range of dominant and recessive IRD phenotypes. Of the 20 most prevalent variants identified, 5 were not in the most common genes; these included founder variants in CNGB3, BBS1, TIMP3, EFEMP1, and RP1. We describe the most common pathogenic IRD alleles in a large single-center multiethnic UK cohort and the burden of disease, in terms of families affected, attributable to these variants. Our findings will inform IRD diagnoses in future patients and help delineate the cohort of patients eligible for gene-directed therapies under development. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

18 June 2025 in Nature Machine Intelligence
Verified
Journal Article
Open access
PDF file
NPNikolas Pontikos
Nikolas Pontikos
WWWilliam A. Woof
William A. Woof
SLSiying Lin
Siying Lin
BGBiraja Ghoshal
Biraja Ghoshal
BMBernardo S. Mendes
Bernardo S. Mendes
MMMichel Michaelides
Michel Michaelides
Rare eye diseases such as inherited retinal diseases (IRDs) are challenging to diagnose genetically. IRDs are typically monogenic disorders and represent a leading cause of blindness in children and working-age adults worldwide. A growing number are now being targeted in clinical trials, with approved treatments increasingly available. However, access requires a genetic diagnosis to be established sufficiently early. Critically, the timely identification of a genetic cause remains challenging. We demonstrate that a deep learning algorithm, Eye2Gene, trained on a large multimodal imaging dataset of individuals with IRDs (n = 2,451) and externally validated on data provided by five different clinical centres, provides better-than-expert-level top-five accuracy of 83.9% for supporting genetic diagnosis for the 63 most common genetic causes. We demonstrate that Eye2Gene’s next-generation phenotyping can increase diagnostic yield by improving screening for IRDs, phenotype-driven variant prioritization and automatic similarity matching in phenotypic space to identify new genes. Eye2Gene is accessible online (app.eye2gene.com) for research purposes.

29 August 2018 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
LLLin Li
Lin Li
XJXiaodong Jiao
Xiaodong Jiao
IDIlaria D’aTri
Ilaria D’aTri
FOFumihito Ono
Fumihito Ono
RNRalph Nelson
Ralph Nelson
James Fielding HejtmancikJames Fielding Hejtmancik
James Fielding Hejtmancik
We identified a homozygous missense alteration (c.75C>A, p.D25E) in CLCC1, encoding a presumptive intracellular chloride channel highly expressed in the retina, associated with autosomal recessive retinitis pigmentosa (arRP) in eight consanguineous families of Pakistani descent. The p.D25E alteration decreased CLCC1 channel function accompanied by accumulation of mutant protein in granules within the ER lumen, while siRNA knockdown of CLCC1 mRNA induced apoptosis in cultured ARPE-19 cells. TALEN KO in zebrafish was lethal 11 days post fertilization. The depressed electroretinogram (ERG) cone response and cone spectral sensitivity of 5 dpf KO zebrafish and reduced eye size, retinal thickness, and expression of rod and cone opsins could be rescued by injection of wild type CLCC1 mRNA. Clcc1+/- KO mice showed decreased ERGs and photoreceptor number. Together these results strongly suggest that intracellular chloride transport by CLCC1 is a critical process in maintaining retinal integrity, and CLCC1 is crucial for survival and function of retinal cells. Retinitis pigmentosa (RP) is a group of conditions that affect the functioning of the light receptor cells in the eye. The first symptom of RP is usually reduced night vision, then loss of peripheral vision, then later loss of central vision. It can eventually lead to complete blindness. A number of genes have previously been shown to cause RP. In this paper we present eight families, all likely to share a common Pakistani ethnicity, each with multiple members with autosomal recessive RP. They all share a newly-identified homozygous genetic variant in the gene CLCC1, encoding a putative protein channel present inside all cells. Our studies demonstrate that alterations to this gene and protein channel specifically affect cell survival and eye development in cell culture, as well as retinal structure and physiology in genetically-altered zebrafish and mice. This is the first identification of CLCC1 as a cause of human disease and enables improved understanding of the molecules important for eye development and function, as well as providing a genetic diagnosis for families with RP. Subsequent studies of this molecule may ultimately suggest novel treatment approaches.

26 February 2025 in Nature
Verified
Journal Article
Open access
PDF file
VCValentina Cipriani
Valentina Cipriani
LVLetizia Vestito
Letizia Vestito
EMEmma F Magavern
Emma F Magavern
JJJulius Jacobsen
Julius Jacobsen
GAGavin Arno
Gavin Arno
DSDamian Smedley
Damian Smedley
Up to 80% of rare disease patients remain undiagnosed after genomic sequencing 1 , with many probably involving pathogenic variants in yet to be discovered disease–gene associations. To search for such associations, we developed a rare variant gene burden analytical framework for Mendelian diseases, and applied it to protein-coding variants from whole-genome sequencing of 34,851 cases and their family members recruited to the 100,000 Genomes Project 2 . A total of 141 new associations were identified, including five for which independent disease–gene evidence was recently published. Following in silico triaging and clinical expert review, 69 associations were prioritized, of which 30 could be linked to existing experimental evidence. The five associations with strongest overall genetic and experimental evidence were monogenic diabetes with the known β cell regulator 3,4 UNC13A , schizophrenia with GPR17 , epilepsy with RBFOX3 , Charcot–Marie–Tooth disease with ARPC3 and anterior segment ocular abnormalities with POMK . Further confirmation of these and other associations could lead to numerous diagnoses, highlighting the clinical impact of large-scale statistical approaches to rare disease–gene association discovery.

13 January 2022 in npj Genomic Medicine
Verified
Journal Article
Open access
PDF file
SLSiying Lin
Siying Lin
ASAida Sanchez-Bretaño
Aida Sanchez-Bretaño
JLJoseph S. Leslie
Joseph S. Leslie
KWKatie B. Williams
Katie B. Williams
HLHelena Lee
Helena Lee
JSJay Self
Jay Self
Oculocutaneous albinism type 1 (OCA1) is caused by pathogenic variants in theTYR(tyrosinase) gene which encodes the critical and rate-limiting enzyme in melanin synthesis. It is the most common OCA subtype found in Caucasians, accounting for ~50% of cases worldwide. The apparent ‘missing heritability’ in OCA is well described, with ~25–30% of clinically diagnosed individuals lacking two clearly pathogenic variants. Here we undertook empowered genetic studies in an extensive multigenerational Amish family, alongside a review of previously published literature, a retrospective analysis of in-house datasets, and tyrosinase activity studies. Together this provides irrefutable evidence of the pathogenicity of two commonTYRvariants, p.(Ser192Tyr) and p.(Arg402Gln) when inherited incisalongside a pathogenicTYRvariant intrans. We also show that homozygosity for the p.(Ser192Tyr)/p.(Arg402Gln)TYRhaplotype results in a very mild, but fully penetrant, albinism phenotype. Together these data underscore the importance of including theTYRp.(Ser192Tyr)/p.(Arg402Gln) incishaplotype as a pathogenic allele causative of OCA, which would likely increase molecular diagnoses in this missing heritability albinism cohort by 25–50%.

9 January 2026 in Nature Genetics
Verified
Journal Article
Open access
PDF file
MQMathieu Quinodoz
Mathieu Quinodoz
KRKim Rodenburg
Kim Rodenburg
ZCZuzana Cvackova
Zuzana Cvackova
KKKarolina Kaminska
Karolina Kaminska
SBSuzanne de Bruijn
Suzanne de Bruijn
CRCarlo Rivolta
Carlo Rivolta
Small nuclear RNAs (snRNAs) combine with specific proteins to generate small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. U4 snRNA forms a duplex with U6 and, together with U5, contributes to the tri-snRNP spliceosomal complex. Variants in RNU4-2, which encodes U4, have recently been implicated in neurodevelopmental disorders. Here we show that heterozygous inherited and de novo variants in RNU4-2 and in four RNU6 paralogs (RNU6-1, RNU6-2, RNU6-8 and RNU6-9), which encode U6, recur in individuals with nonsyndromic retinitis pigmentosa (RP), a genetic disorder causing progressive blindness. These variants cluster within the three-way junction of the U4/U6 duplex, a site that interacts with tri-snRNP splicing factors also known to cause RP (PRPF3, PRPF8, PRPF31), and seem to affect snRNP biogenesis. Based on our cohort, deleterious variants in RNU4-2 and RNU6 paralogs may explain up to ~1.4% of otherwise undiagnosed RP cases. This study highlights the contribution of noncoding RNA genes to Mendelian disease and reveals pleiotropy in RNU4-2, where distinct variants underlie neurodevelopmental disorder and retinal degeneration.